Osteomodulin attenuates smooth muscle cell osteogenic transition in vascular calcification

RATIONALE: Vascular calcification is a prominent feature of late‐stage diabetes, renal and cardiovascular disease (CVD), and has been linked to adverse events. Recent studies in patients reported that plasma levels of osteomodulin (OMD), a proteoglycan involved in bone mineralisation, associate with...

Descripción completa

Detalles Bibliográficos
Autores principales: Skenteris, Nikolaos T., Seime, Till, Witasp, Anna, Karlöf, Eva, Wasilewski, Grzegorz B., Heuschkel, Marina A., Jaminon, Armand M.G., Oduor, Loureen, Dzhanaev, Robert, Kronqvist, Malin, Lengquist, Mariette, Peeters, Frederique E.C.M., Söderberg, Magnus, Hultgren, Rebecka, Roy, Joy, Maegdefessel, Lars, Arnardottir, Hildur, Bengtsson, Eva, Goncalves, Isabel, Quertermous, Thomas, Goettsch, Claudia, Stenvinkel, Peter, Schurgers, Leon J., Matic, Ljubica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858609/
https://www.ncbi.nlm.nih.gov/pubmed/35184400
http://dx.doi.org/10.1002/ctm2.682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858609/
https://www.ncbi.nlm.nih.gov/pubmed/35184400
http://dx.doi.org/10.1002/ctm2.682

Ejemplares similares